(Q41666121)

English

A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study

scientific article published on January 1995

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

H J Möller

1

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

H Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

R L Borison

3

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

N R Schooler

4

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

G Chouinard

5

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

European Archives of Psychiatry and Clinical Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

245

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

45-49

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Treatment of negative symptoms

1 reference

https://api.crossref.org/works/10.1007%2FBF02191543

21 January 2018

Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent?

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroleptic-induced parkinsonism in older schizophrenics

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deficit and nondeficit forms of schizophrenia: the concept

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine's effect on negative symptoms in treatment-refractory schizophrenics

1 reference

https://pubmed.ncbi.nlm.nih.gov/7540426

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02191543

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41666121&oldid=2204694798"